ArticleFrontiers in pharmacology2024

A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer.

Jie Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.